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Background: Cases of endometriosis with no tubal damage are associated with infertility, suggesting an
immunological rather than mechanical barrier to reproduction. Laparoscopy and falloposcopy results of clinically
asymptomatic women undergoing investigation of infertility were correlated with the outcomes of
microbiological screening for Chlamydia trachomatis, Mycoplasma pneumoniae, Mycoplasma hominis,
ureaplasma species, Neisseria gonorrhoeae, Neisseria meningitidis and Chlamydia pneumoniae.
Methods: A total of 44 women presenting to a hospital IVF service for laparoscopic or laparoscopic/
falloposcopic investigation of infertility provided endocervical swabs, fallopian tube washings, and peripheral
whole blood for analysis.
Results: Of these 44 women, 15.9% (7) showed evidence of C. trachomatis infection as detected by either PCR
or EIA serology. Of these 7 women, 5 (71%) had no or mild endometriosis and 2 (29%) had moderate or
severe endometriosis. Of the remaining 37 women who showed no evidence of chlamydial infection, 15
(40.5%) had no or mild endometriosis.
Conclusion: Women with infertility, but without severe endometriosis at laparoscopy, showed a trend towards
tubal damage and a higher rate of previous C. trachomatis infection. Although not statistically significant, this
trend would suggest that, where moderate to severe tubal damage is found to be the primary cause of
infertility, C. trachomatis infection could be a likely cause for such tubal damage.
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INTRODUCTION
Intraluminal pathology of the fallopian tube is
correlated with two conditions—pelvic inflam-
matory disease (PID) and endometriosis. The
presence of such tubal disease is a strong
determinant of infertility1; 20 to 25% of infertile
women have been shown to have endometriosis
compared with 2 to 5% of fertile women2, and up
to a third of women with endometriosis show
evidence of salpingitis3. Whereas severe cases of
endometriosis accompanied by extensive pelvic
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adhesions can lead to tubal infertility, mild or
moderate cases with no tubal damage are also
associated with infertility, suggesting an immu-
nological rather than a mechanical barrier to
reproduction4,2.
PID also causes tubal infertility. The severity of
tubal damage occurring during PID determines
the probability of infertility: 3% of women with
mild tubal damage observed at laparoscopy, 13%
with moderate damage, and 29% with severe
damage, were identified as having tubal inferti-
lity5. Despite the high causal relationship between
bacterial infection and PID, organisms are rarely
isolated in PID cases, and even less frequently in
cases of tubal infertility6.
Most women with tubal infertility do not have a
history of recognised acute salpingitis. However, a
number of previous studies investigating acute
infections, pelvic inflammatory disease and salpin-
gitis have demonstrated that Chlamydia trachomatis
and Neisseria gonorrhoeae are the most common
causes of such infection7–10; and others have
demonstrated an abnormally high prevalence of
antichlamydial (C. trachomatis) antibodies inwomen
with tubal infertility and ectopic pregnancy11–15.
In this study we investigated the severity of
intraluminal disease, endometriosis and evidence
for microorganisms associated with PID among a
cohort of clinically asymptomatic women under-
going laparoscopy or laparoscopy/falloposcopy for
the investigation of infertility. The objectivewas to
determine the prevalence of, and possible relation-
ship between, asymptomatic infection and path-
ology of the fallopian tubes consequent to endo-
metriosis and PID. This study reports on patho-
logical findings at laparoscopy or laparoscopy/
falloposcopy, and outcomes of micro-biological
screening for microorganisms including C.
trachomatis, M. pneumoniae, M. hominis, ureaplasma
species, N. gonorrhoeae and N. meningitidis, and
serological testing forC. trachomatis, C. pneumoniae
andM.pneumoniae.
MATERIALS AND METHODS
Participants
This study involved 44 women presenting to a
hospital IVF service for laparoscopic and fallopo-
scopic investigation of infertility. These women
had a history of infertility of at least 2 years’
duration, were clinically asymptomatic for PID,
and either had a history of signs and symptoms
suggestive of endometriosis, or a previous diag-
nosis of tubal disease as confirmed by previous
laparoscopy, or longstanding unexplained inferti-
lity. All subjects had had other forms of infertility
investigated (male factor, ovulation defects)
before undergoing laparoscopy or laparoscopy/
falloposcopy. Informed consent was obtained
from all participants and the study was approved
by the human ethics committees of the Queens-
land University of Technology and the Wesley
Hospital, Brisbane, Queensland.
Clinical samples
Three separate clinical samples were collected
from each of the participants: endocervical swabs
for culture and PCR analysis; fallopian tube
washings for culture, PCR analysis and serology;
and 10 ml peripheral whole blood for serological
assay. The endocervical swabs were collected
during a speculum examination before the
laparoscopy/falloposcopy procedure. The cervix
was then prepared for falloposcopy and swabbed
with povidone iodine. As a matter of protocol, all
women were treated with antibiotics before the
insertion of instrumentation through the cervix,
in order to reduce the possibility of pelvic
infection due to contamination carried from the
vagina. Cefotaxamine sodium, 2 g intravenously,
was administered at the commencement of the
procedure.
During falloposcopy an endoscope (Imagyn
Medical, Switzerland) was inserted through the
cervix and uterus into the fallopian tubes. The
tubes were visualised along their length by means
of a linear everting catheter and falloposcope.
Saline was passed through the fallopian tube and
any tissue debris or adhesions within the tubal
lumen were cleared if possible during this
procedure. The resultant cellular debris and saline
were collected from the pouch of Douglas by
aseptic aspiration via laparoscopy and aliquotted
for testing. In 5 cases severe tubal pathology
precluded falloposcopic examination, although
saline was forced through under pressure. Thus
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fallopian tube washings were collected in these 5
cases although falloposcopic observation was not
possible.
Classification of endometriosis
The classification of endometriosis employed in
this study was a modification of the American
system, developed specifically with reference to
fertility outcomes. Laparoscopic observations of
endometriosis were classified according to the
extent and distribution of endometriosis and the
presence of adhesions. The presence of some
peritoneal endometriosis deposits, with no en-
dometriosis on tubes or ovaries and no pelvic
adhesions, was classed as mild. The presence of
peritoneal endometriosis deposits and/or pelvic
adhesions, with superficial endometriosis deposits
on the ovarian capsule but no periovarian or
peritubal adhesions, was classed as moderate.
Endometrioma formation in the ovaries, exten-
sive peritoneal endometriosis, extensive pelvic
adhesions, and deposits of endometriosis on tubal
serosa with or without peritubal/periovarian
adhesions constituted severe endometriosis.
Classification of intraluminal disease
Falloposcopy findings observed inside the fallo-
pian tubes were classified as follows. Minimal loss
of intraluminal folds with no adhesions or
obstruction in either fallopian tube was classed
as mild. Complete obstruction of one or in-
complete obstruction of either one or both tubes,
with moderate adhesions and moderate loss of
tubal mucosal folds, was classed as moderate.
Intraluminal tubal pathology (found at fallopo-
scopy to be the primary cause of infertility) with
permanent bilateral obstruction or extensive loss
of normal intraluminal tubal architecture (pre-
sence of intratubal adhesions and loss of tubal
mucosal folds) constituted severe disease.
Detection of C. trachomatis and neisseria
species.
Endocervical swabs were tested by Amplicor
CT/NG PCR (Roche Diagnostics, Branchburg,
NJ, USA) for both C. trachomatis and N.
gonorrhoeae (according to the manufacturer’s
instructions), and cultured for N. meningitidis
using chocolate agar incubated overnight at
358C. Samples of fallopian tube washings
obtained from falloposcopy and/or laparoscopy
were also tested for C. trachomatis by the Roche
Amplicor CT/NG PCR and cultured for both
N. gonorrhoeae and N. meningitidis using Thayer
Martin/chocolate agar. The Roche Amplicor
CT/NG PCR method incorporates an internal
control to monitor for the presence of PCR
inhibitors.
Antibody screening
Peripheral blood serum and fallopian tube
washings collected from participants were tested
for anti-C. trachomatis IgG and IgA antibodies
and anti-C. pneumoniae IgG antibodies. C.
trachomatis antibodies were detected using the
Labsystems Chlamydia trachomatis IgG EIA and
IgA EIA (Helsinki, Finland). C. pneumoniae IgG
antibodies were detected by immunofluores-
cence using the FOCUS Chlamydia MIF (Los
Angeles, USA). An agglutination assay (Fujir-
ebio Serodia-MYCOII, Japan) was selected for
determination of M. pneumoniae antibodies using
washings only.
Serum samples were tested and interpreted for
C. trachomatis and C. pneumoniae antibodies
according to the manufacturer’s instructions. As
no criteria were supplied for samples other than
blood, the following adaptations were made for
testing the fallopian fluids. Samples of C.
trachomatis were initially tested undiluted; if
positive, they were retested at dilutions of 1:2
and 1:10 prepared using sample diluent. C.
pneumoniae samples were initially tested at 1:16
dilution; and M. pneumoniae samples were initially
tested at 1:4 dilution.
Ureaplasma/ mycoplasma detection
Ureaplasma culture
Endocervical swabs (39 samples tested) and
fallopian tube washings (40 samples tested) were
inoculated directly into 10B broth16 and then
held at – 808C until testing. In the laboratory,
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four serial 10-fold dilutions were made of the
liquid broth, which was then incubated at 378C
until ureaplasma growth was detected by an
alkaline shift or for 3 weeks.
Ureaplasma/mycoplasma PCR detection
All clinical samples were prepared for extraction
of DNA by the method of Blanchard et al17. All
endocervical and fallopian tube clinical samples
were tested by PCR assay for the presence of
ureaplasmas. M. hominis and all endocervical
ureaplasma isolates identified as U. parvum were
further subtyped using four separate single-step
mba PCR assays by previously described meth-
ods18. For M. pneumoniae testing, primers specific
for the species were designed using the P1 and
ORF453 genes of M. pneumoniae and an anneal-
ing temperature of 528C. Primers were designed
to avoid regions of high homology with Myco-
plasma genitalium and Ureaplasma urealyticum
sequences. ORF 453 encodes a possible proto-
porphyrinogen oxidase, and primers ORF-F (5’
TCAACTACCCT-TACCCTATTACC 3’) and
ORF-R (5’ GCACTCCAGTATCACTTGTT-
TAAC 3’) generate an amplicon of 505 bp.
Primers to the P1 major adhesin of M. pneumoniae
were designed in the constant region 1 to avoid
repetitive elements19 and variable regions20. PCR
amplification using primers P1-F (5’
CTTACTGT-TCTCAGGCATGG 3’) and P1-
R (5’ TTGACAAGACCGTCCA-ATCC 3’)
produced a fragment of 383 bp. M. pneumoniae
DNA kindly supplied by G. Browning, Uni-
versity of Melbourne, was used as a control. The
PCR reaction mixture and thermal cycling
conditions were those previously described18.
Other bacteriological culture
An endocervical swab was also cultured on horse
blood and Sabouraud’s dextrose agar and incu-
bated overnight at 358C.
Statistical analysis
Associations of chlamydia infection between
women with nil/mild and moderate/severe en-
dometriosis and tubal disease were examined by
two-way tables using chi-squared and Fisher’s
exact tests.
RESULTS
Laparoscopy and falloposcopy results
Of the 44 women enlisted in this study, 5
underwent a laparoscopy procedure but did not
proceed to falloposcopy; however, in these cases
fallopian tube washings were obtained as a result
of saline being washed through. All of these 5
women were noted to have peritubal adhesions
on external examination by laparoscopy, and their
tubal disease was consequently classified as
moderate to severe. On laparoscopy, 40 (90.9%)
of the 44 women were found to have endome-
triosis which was classified as mild in 16 (36.4%)
cases, as moderate in 15 (34.1%) cases, and as
severe in 9 (20.5%) cases. The presence of
fallopian tubal disease as identified by fallopo-
scopy and/or external laparoscopy was identified
as moderate to severe in 38/44 (86.4%) partici-
pants, and nil or mild in the remaining 6 (13.6%)
participants. Of the other 4 women who recorded
no diagnosis of endometriosis, all recorded severe
tubal obstructions on falloposcopy; 7 women with
mild endometriosis also showed severe, bilateral
obstructions within the fallopian tubes.
Endocervical culture/PCR results
Ureaplasmas were detected by culture and PCR
in 11/39 (28.2%) of the endocervical samples
tested and were identified as U. parvum. These U.
parvum isolates were subsequently subtyped; 7/12
(58%) were serovar 3 isolates, 1/12 (8.3%) were
serovar 1, and 4/12 (33%) were serovar 6. Mixed
serovars 1 and 3 were detected in 1 of the
endocervical samples. M. hominis, M. pneumoniae,
C. trachomatis, N. gonorrhoeae and N. meningitidis
were not detected in any of the endocervical
samples by PCR and/or culture. Culture of
endocervical samples further identified mild
growth of bacteroides species in 1/44 (2.3%)
women, mild growth of Candida albicans in 1/44
women (2.3%), and moderate growth of group B
streptococcus in 5/44 (11.4%) women, 1 of
whom was coinfected with Gardnerella vaginalis.
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Endocervical cultures for the remaining women
grew the bacterial flora that could normally be
expected after vaginal contamination.
Fallopian tube culture/PCR results
C. trachomatiswas detected in the fallopian tubes of
1 woman (Table 1). Serology for both fallopian
washings and serum for this woman was found to
be negative for C. trachomatis, and no other
fallopian tube sample was found to be positive
for C. trachomatis. Ureaplasmas, M. hominis, M.
pneumoniae, N. gonorrhoeae andN. meningitidiswere
not detected in any of the fallopian tube samples.
Antibody testing
Both serum and fallopian tube fluids were
available for serological testing for 38 of the 44
women; for 3 women only serum was tested and
for 3 only fallopian tube fluid was tested.
Peripheral blood serology
Of the 41 serum samples, 4 (9.8%) were positive
for C. trachomatis IgG, and 1 (2.4%) for C.
trachomatis IgA (Table 1). Positive results for both
IgG and IgA anti-C. trachomatis antibodies were
found in 1 sample, and 1 demonstrated a positive
IgG and an equivocal IgA anti-C. trachomatis
antibody level; 25/36 samples (69.4%) were
positive for C. pneumoniae IgG.
Fallopian tube serology
Of the 41 fallopian tube washings, 5 (12.2%) were
positive for the presence of C. trachomatis IgG, 1
(2.4%) for C. trachomatis IgA (Table 1), 5 (12.2%)
for C. pneumoniae IgG, and 1 (2.4%) for M.
pneumoniae serology. In 1 case both IgG and IgA
anti-C. trachomatis antibodies were found in both
the fallopian tube and serum.
Association of laparoscopic and falloposcopic
findings with serology/microbiological results
Evidence (either in peripheral blood or fallopian
tube washings) of C. trachomatis infection was
found in 7 women (Table 1). Nil or mild
endometriosis was diagnosed in 5 (71%) of these,
and 4 of the 5 were also shown to have moderate
to severe intraluminal disease according to
falloposcopic observation. Participant 32 (Table
1) showed no evidence of endometriosis but had
severe tubal disease with extensive bilateral
damage. Only participants 14 and 31 (Table 1)
had endometriosis classified as moderate and
severe, respectively, and both these women had
severe tubal disease showing extensive adhesions
and scarring. Participant 14 was also the 1 woman
with a C. trachomatis infection in the fallopian
tube detectable by PCR, although serology was
negative. Therefore, in total, 6 (86%) of the 7
women with evidence of chlamydial infection
showed moderate to severe intraluminal disease
Table 1 Combined results of serum and fallopian tube C. trachomatis pathology
Case Serum IgG Serum IgA Fallopian IgG Fallopian IgA Endometriosis
Intraluminal
disease
Patient 12 + - + - Mild Moderate
Patient 14, PCR
+ ve
- - - - Moderate Severe
Patient 17 + Equivocal - - Mild Severe
Patient 29 + - + - Mild Nil
Patient 31 - - + - Severe Severe
Patient 32 + + + + Nil Severe
Patient 36 – – + - Mild Severe
Total positives 4 1 5 1
Total patients 41 41 41 41
Percentage
+ ve
9.8% 2.4% 12.2% 2.4%
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but only 2 (28.6%) of these 7 women had
moderate to severe endometriosis.
In 1 case with positive mycoplasma serology
(fallopian tube fluid), mild endometriosis was
defined, with severe tubal disease and a history of
ruptured appendicitis.
Of the remaining 37 women who showed no
microbiological evidence of chlamydial infection,
11 (29.7%) had a diagnosis of mild endometriosis,
13 (35.1%) of moderate endometriosis, and 9
(24.3%) of severe endometriosis, whereas 4
(10.8%) had no endometriosis. According to
falloposcopic observations, 5 (13.5%) of women
in this same group had no or mild tubal disease and
32 (86.5%) had moderate to severe tubal disease.
The laparoscopy and falloposcopy results for
those women with C. trachomatis positivity, and
those with none, were grouped into two general
categories of endometriosis and tubal disease (nil/
mild and moderate/severe) and are described in
Table 2.
Among the women with evidence of chlamy-
dial infection, 71% had a diagnosis of nil/mild
endometriosis diagnosis compared with 40.5% of
women with no evidence of chlamydia (p4 0.5).
Among the women with evidence of chlamydia
and classifications of nil/mild endometriosis,
56.7% showed moderate/severe tubal damage
compared with 32.4% of women without positive
chlamydia serology and with nil/mild endome-
triosis (p4 0.5).
The 9 women with endocervical ureaplasma
infection were evenly distributed across both
groups of endometriosis: 44% had nil/mild
endometriosis and 56% had moderate/severe
endometriosis.
A review of the clinical histories of the
participants showed that of the 7 women with
evidence of C. trachomatis infection, 1 gave a
history of miscarriage, 1 gave a history of ectopic
pregnancy, and 2 had had PID previously.
Another 2 participants in this group displayed
significant tubal disease indicative of previous
infection. In comparison, the clinical histories of
the other 37 women included (in addition to
endometriosis) 5 cases of polycystic ovarian
disease, 4 of irregularities with ovulation, 1 of
possible PID at a very early age (no tubal disease
was detected), 1 of hydrosalpinx, 1 of suspected
infection from a previous termination of preg-
nancy and 2 of appendicitis.
When serum samples were assayed for C.
pneumoniae, equivalent proportions of patients
with either nil/mild or moderate/severe endo-
metriosis were found to have positive serology for
C. pneumoniae (44% and 56%, respectively).
DISCUSSION
C. trachomatis is now recognised as one of the
most common sexually transmissible bacterial
pathogens throughout the world. C. trachomatis
has previously been found to be the primary cause
of salpingitis and pelvic inflammatory disease (30
to 60% of cases)7–10,21, often with consequent
ectopic pregnancy22 and tubal infertility23,24. The
presence of C. trachomatis DNA at sites of
inflammation and tissue damage within repro-
ductive tissue in both animal models25 and
humans with PID and tubal infertility26–29
suggests that chlamydia persist within the fallopian
tube in a non-replicative chronic state and may be
directly involved in the stimulation of the
immune-mediated tissue destruction.
However, despite strong evidence of C.
trachomatis involvement in tubal infertility, isola-
tion of the organism by culture is rare28.
Falloposcopy as performed for this cohort of
women remains one of the few options for
obtaining fallopian tissue for analyses. However,
in our study tissue biopsies were not taken. In
view of the intracellular reproductive cycle of C.
Table 2 C. trachomatis pathology in different categories
of endometriosis and intraluminal disease: numbers (%) of
cases
Tubal disease
Nil/mild
endometriosis
Moderate/
severe
endometriosis
Positive for C. trachomatis
–nil/mild 1 (14.3%) –
–moderate/severe 4 (56.7%) 2 (29.0%)
–total (n=7) 5 (71.0%) 2 (29.0%)
Negative for C. trachomatis
–nil/mild 3 (8.1%) 2 (5.5%)
–moderate/severe 12 (32.4%) 20 (54.0%)
–total (n=37) 15 (40.5%) 22 (59.5%)
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trachomatis, the collection of luminal tissue for
testing is ideal, but the process of clearing out
debris by means of the passage of saline through
the fallopian tube was considered sufficient in our
study to provide suitable material for PCR
testing. Nonetheless, one deficiency in this
approach was our failure to collect pre-existing
cul-de-sac fluid before aspiration of the tubal
effluent.
This study reports the microbiological screen-
ing of cervical, serum and fallopian tube samples
collected from women undergoing laporoscopic
and/or falloposcopic investigation for infertility.
A total of 7 women (15.9%) within our cohort of
44 women showed evidence of previous C.
trachomatis infection, either in the form of serum
IgG (n=4) and/or IgA antibodies (n=1), fallo-
pian tube IgG (n=5) and/or IgA (n=1)
antibodies, or chlamydial DNA detected by
PCR in the fallopian tube washings (n=1). This
prevalence, recorded in a population of women
accessing an infertility service, is as expected
higher than both the general and antenatal
prevalence rates. The prevalence of 3 to 5% in
the general community was calculated from
urine-based PCR among, for example, adult
clients attending the Brisbane Sexual Health
Clinic on any given month (unpublished data).
The antenatal prevalence of 3.7% was previously
reported in antenatal patients attending a public
hospital clinic30.
The prevalence (15.9%) found in this study is
comparable with that reported by other studies. In
a previous study of 1303 subfertile couples,
asymptomatic for genital tract infection, elevated
titres of IgG anti-chlamydial antibodies were
found in 20.8% of all women11. Similarly
Vogelzang et al.31, in a study of infertile women
referred to an IVF provider for diagnostic
laparoscopy, found that 7/33 (21.2%) women
with tubal disorders (adhesions, distal occlusions
and strictures) demonstrated antibodies to C.
trachomatis compared with 0/20 of women with-
out tubal damage. Further studies have also
strongly supported the link between serological
evidence of previous C. trachomatis infections and
tubal infertility and ectopic pregnancies12–15.
The detection of antibodies to C trachomatis
within fallopian tube washings collected does not
necessarily reflect actual antibody production in
the tubes but could also be the result of serum
transudate or contamination by blood washed
through with the dislodged cellular debris and
fragments of endometrium.
In this current study we also compared the
prevalence and severity of endometriosis in
women positive and negative for C. trachomatis.
Although there was no statistical significance,
there appeared to be a trend in which a higher
proportion of those infertility clinic clients
returning a positive C. trachomatis diagnosis
recorded nil/mild categories of endometriosis
(5/7: 71%) compared with those women without
any evidence for C. trachomatis (15/37: 40.5%).
Also, there was a trend in which a lower
proportion of positive C. trachomatis diagnoses
recorded moderate/severe categories of endome-
triosis (2/7: 29%) compared with the negative
group (22/37: 59.5%). Again this was not
significant in view of the small numbers. These
results suggest a negative relationship between C.
trachomatis and endometriosis. Therefore, in this
current study, endometriosis appears not to be
associated with a previous history of C. trachomatis
infection. A previous study had similarly found
that only 1/15 patients with endometriosis had
detectable antibodies to C. trachomatis14.
The majority of participants in this present
study were found during falloposcopy to have
moderate/severe intraluminal disease (38/44:
86.4%). Moderate/severe tubal damage was ob-
served in women with both nil/mild and
moderate/severe endometriosis (87.1% and
80.4%, respectively). Therefore the severity of
the tubal damage did not relate to the endome-
triosis classification. 16/44 (36%) of the women in
our study presented with moderate to severe tubal
damage in the absence of moderate to severe
endometriosis. Although 25% (4/16) of these
women showed evidence of C. trachomatis infec-
tion, the aetiology of tubal damage for the
remaining 12 women remained undefined.
When both endometriosis and tubal disease
were investigated together, 56.7% of participants
with positive C. trachomatis findings had moder-
ate/severe tubal disease and nil/mild
endometriosis, whereas only 32.4% of participants
without evidence of C. trachomatis infection had
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similar categories of intraluminal disease and
endometriosis. Therefore the findings of tubal
damage in those women with evidence of C.
trachomatismay be due to this previous infection, in
view of the fact that endometriosis was predomi-
nantly mild or non-existent for this group.
A more speculative explanation for the higher
prevalence of C. trachomatis among this small
sample of women with nil/mild endometriosis
may be a protective effect. Could C. trachomatis
infection limit the extent and severity of en-
dometriosis or, conversely, does a pre-existing
endometriosis condition limit C. trachomatis
infection? It may be possible that tubal occlusion
resulting from C. trachomatis infection may create
a physical barrier against endometrial tissue
passing through the fallopian tube or, alterna-
tively, immune responses generated during
endometriosis such as elevated cytokine expres-
sion2,32,33, increased neutrophil activity34–36 and
increased phagocytic activity37,38 may clear chla-
mydial colonisation before the development of
florid infection.
The prevalence of C. pneumoniae antibodies in
sera was evenly distributed across both classifica-
tions of endometriosis (Table 3), and there did
not appear to be an association with C.
trachomatis serology. Freidank et al.39 showed a
higher anti-hsp60 antibody rate in patients with
complete tubal occlusion (76%) than in infertility
patients with normal fallopian tubes (19%), and
this was associated with the presence of
antibodies not only to C. trachomatis but also to
C. pneumoniae, suggesting a synergistic effect due
to cross-reactivity. However, Osser and Pers-
son40 had earlier argued against the possibility of
cross-reactivity due to shared antigens by
demonstrating that antibodies to C. pneumoniae
did not influence the frequency or titre of
antibodies to C. trachomatis in patients recovering
from acute salpingitis. C. trachomatis antibodies,
however, did reflect the severity of inflammatory
involvement. More recently41, patients with
tubal factor infertility were shown to have
significantly higher frequencies and titres for all
antibodies (C. trachomatis hsp60, hsp10, common
chlamydial lipopolysaccharide) except to C.
pneumoniae. No interaction between C. tracho-
matis and C. pneumoniae suggestive of a
synergistic effect was found. The results of our
study would suggest a similar trend, although the
numbers of patients were too small for statistical
significance.
In this study we also tested endocervical
swabs and fallopian tube washings for the
presence of the ureaplasmas (U. parvum, U.
urealyticum), M. hominis and M. pneumoniae.
Whereas M. hominis and M. pneumoniae were
not detected in either endocervical or fallopian
tube samples, 28% of the women tested were
found to have U. parvum in the endocervix.
However, no ureaplasmas were detected in the
fallopian tube washings by either culture or
PCR. Testing of the fallopian tube specimens
using a more sensitive nested mba PCR assay
(results not shown) also failed to detect
ureaplasmas within these specimens. These
results confirm that the fallopian tube specimens
had not been contaminated during the trans-
cervical falloposcopy procedure.
Previous studies demonstrated a very low
isolation rate of the ureaplasmas (0 to 3%) and
M. hominis (0 to 4%) from the fallopian tubes7,9.
This is despite higher ureaplasma/M. hominis
colonisation rates in the endocervix (48 to 52%)
and the endometrium (6 to 30%). However, these
studies highlighted the increased prevalence of C.
trachomatis: 30% of women were infected with C.
trachomatis in the endometrium and 17 to 22% of
women demonstrated infection within fallopian
tubes7,9. M. pneumoniae was not detected in either
endocervical or fallopian tube samples in this
current study, but this microorganism has been
associated with orogenital contact and has been
isolated from cervical and male urethral swabs42.
A rare case of tubo-ovarian abscess has also been
reported after pneumonia, indicating the possibi-
lity of systemic spread43.
Table 3 Correlation of C. pneumoniae serology with
endometriosis rating: numbers (%) of cases
Endometriosis
rating
Positive C.
pneumoniae
serology (n=25)
Negative C.
pneumoniae
serology (n= 11)
Nil/mild 11 (44%) 6 (55%)
Moderate/severe 14 (56%) 5 (45%)
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Our study also shows that there is no
association between the prevalence of endome-
triosis and U. parvum, given that 44.4% of women
with endocervical ureaplasmas had nil/mild en-
dometriosis compared with 55.6% of ureaplasma-
positive women with moderate/severe endome-
triosis.
N. meningitidis, another respiratory pathogen
and coloniser, has also been isolated from the
female genitourinary tract in both symptomatic
and asymptomatic states, and is generally asso-
ciated with orogenital contact43. Symptomatic
infections range from urethritis to purulent
cervicitis and salpingitis. In our population sample
of 44 women, no N. meningitidis was isolated from
either cervix or fallopian tube by culture.
Whereas the prevalence of anogenital infection
in the UK has remained very low at 0.13%, other
studies in the USA have isolated N. meningitidis in
20% of cases urogenital detection of pathogenic
Neisseria species43.
Other organisms identified in the endocervix
of these women were considered consistent with
lower genital tract flora, as no participants in the
study had symptoms of PID or vaginitis.
The evidence for C. trachomatis infection
identified in 15.9% of women involved in this
study was comparable with previous studies and
was certainly higher than the prevalence (3.7%)
within a population of fertile Australian wo-
men30. The absence of C. trachomatis indicators in
women with moderate to severe endometriosis,
and the comparable rates of women with and
without evidence for ureaplasma across all group-
ings of endometriosis, supports a non-microbial
cause for endometriosis. Further, this study may
suggest a protective effect by which previous
chlamydial-induced tubal damage may limit the
spread of endometriosis, or immune responses
associated with endometriosis may prevent chla-
mydia infection. Our study also suggested that
there was no synergistic link between C.
pneumoniae and C. trachomatis infection with
respect to inducing tubal damage. Finally, a third
of the women in our group who presented with
moderate to severe intraluminal disease had no
significant evidence of endometriosis. Whereas
25% of this group showed some evidence for
previous C. trachomatis infection, there remained a
majority with no apparent microbiological cause
for their tubal disease.
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